Move from mom-testing to repeatable pharma customer acquisition

Move from mom-testing to repeatable pharma customer acquisition targets a $200M = 10,000 potential buyers (pharma marketing orgs and specialized agencies globally) x $20,000 ACV total addressable market with medium saturation and a year-over-year growth rate of 8-12% (digital pharma marketing and martech spend growth).

Key trends driving demand: Digital shift in pharma promotion -- marketers moving spend from field sales and conferences to measurable digital channels, increasing demand for optimization tools; Demand for measurable ROI -- pharma finance and marketing expect attribution and impact reporting, creating demand for analytics that tie to revenue; Regulatory scrutiny and compliance -- stricter pharma marketing regulation increases value for solutions that bake compliance into optimization workflows; Vendor consolidation and cloud adoption -- pharma commercial stacks are consolidating, opening integration opportunities for niche optimization services.